GSK-3 inhibitors (Novo Nordisk)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameGSK-3 inhibitors (Novo Nordisk)
Drug Alias NameNNC-92-9035 analogs (Novo Nordisk)NNC-57-0541NNC-57-0511NNC-57-0545NNC-57-0588
ClassificationSmall molecules
Mechanisms of ActionGlycogen synthase kinase-3 beta inhibitorsInsulin sensitizers
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A